Brief: Roquefort Therapeutics Signs Agreement To Sell Lyramid For $10.8 Mln
Feb 3 (Reuters) - Roquefort Therapeutics PLC ROQ.L :
* ROQUEFORT THERAPTCS. - SHARE PURCHASE AGREEMENT SIGNED -
SALE
OF LYRAMID
* ROQUEFORT THERAPEUTICS PLC - SIGNS AGREEMENT TO SELL
LYRAMID FOR
$10.8 MILLION
* ROQUEFORT THERAPEUTICS PLC - TO HOLD MATERIAL EQUITY
POSITION IN
PLEIADES PHARMA
Source text: ID:nRSC6233Va
Further company coverage: ROQ.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coiled Therapeutics
See all newsRCS - Coiled Therapeutics - Investor Presentation via Engage Investor
RCS - Coiled Therapeutics - Participation in The Small Cap Showcase
Coiled Therapeutics - Director/PDMR Shareholding
Coiled Therapeutics - Interim Results to 30 June 2026
Coiled Therapeutics - Successful Enrolment Completed Across Two Cohorts